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AMycobacterium bovis knockout in p27-p55 operon was tested as an antituberculosis experimental vaccine in animal models. The
mutant MbΔp27-p55 was significantly more attenuated in nude mice than its parental strain but more virulent than BCG Pasteur.
Challenge experiments in mice and guinea pigs using M. bovis or M. tuberculosis strains showed similar protection conferred by
MbΔp27-p55 mutant than BCG in terms of pathology and bacterial loads in spleen but lower protection than BCG in lungs. When
tested in cattle, MbΔp27-p55 did not induce IL-2 expression and induced a very low production of IFN𝛾, suggesting that the lack
of P27/P55 reduces the capacity ofM. bovis of triggering an adequate Th1 response.
1. Introduction
Mycobacterium bovis (Mb), the causative agent of bovine
tuberculosis (BTB), infects cattle and other animals, includ-
ing humans [1]. Although vaccination of cattle may represent
an intervention strategy to reduce the impact of BTB on
livestock productivity and human health in the developing
countries, to date there is no available vaccine against BTB.
The gene that encodes P27/LprG constitutes a virulence
operon together with p55 that encodes an efflux pump or
transporter [2]. Although P27 inducesTh1 immune response,
in BALB/c mice, when administrated as vaccine with BCG
produced an adverse effect [2]. Moreover, coadministration
of P27 with M. tuberculosis aggravates the infection [2],
suggesting that this protein plays a role in M. tuberculosis
infection by inducing increased suppression of the immune
response. In this study we investigated the capacity of a
M. bovis strain knockout in p27-p55 operon to induce
protective immune response in cattle and to vaccinate mice
and guinea pigs against infection with virulent M. bovis and
M. tuberculosis, respectively.
2. Results and Discussion
2.1. Examination of MbΔp27-p55 Virulence in Nude Mice. In
order to comply with the safety requirements for a live TB
candidate vaccine we evaluated the virulence of theMbΔp27-
p55 in immunodeficient mice. Nude mice (10 per group)
were infected with 12,500 colony forming units (CFUs) of
the wild type or MbΔp27-p55 strains, and survival was
assessed. The median survival of wild type-infected mice
(59 days) was statistically different (𝑃 < 0.001) to that
of MbΔp27-p55-infected animals (109 days) (Figure 1). This
result demonstrates that MbΔp27-p55 is attenuated in the
absence of a T-cell adaptive immune response and therefore
is a safe candidate to be tested as a TB vaccine.
2.2. Evaluation of MbΔp27-p55 as TB Vaccine Candidate
in Animal Models. The experimental challenge model of
progressive pulmonary tuberculosis was used in this study
[3]. Groups of BALB/c mice (7 per group) were vaccinated
subcutaneously in the base of the tail with 100,000 bacilli of
either the MbΔp27-p55 mutant or BCG Pasteur. At 60 days
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Figure 1: Survival of nude mice after intratracheal inoculation
with 1.25 × 104 CFU of WT (circles), MbΔp27-p55 (squares), or
BCG (triangles) bacteria. Statistical analysis for survival curves was
performed using Mantel-Cox tests (𝑃 < 0.001).
after-vaccination, all mice were challenged intratracheally
with 125,000CFUs of a virulent M. bovis strain. Mice were
then killed at 30 days after-challenge. Levels of protection
were determined by evaluating the numbers of viableM. bovis
strain bacilli recovered from lungs and spleen. The numbers
of CFUs cultured from the organs of each group are shown
in Figure 2(a). Mice vaccinated with either BCG or MbΔp27-
p55 were protected compared to saline control (𝑃 < 0.001), in
both lungs and spleen. However, in the lungs, the protection
conferred by the mutant was statistically lower than that of
BCG (𝑃 < 0.05).
Groups of 8 Dunkin-Hartley guinea pigs were used to
evaluate the efficacy of MbΔp27-p55 compared with BCG
Danish 1331 both delivered subcutaneously in a single dose
at a concentration of 5 × 104 CFU. Twelve days after-
immunization, animals were infected with a low aerosol dose
ofM. tuberculosisH37Rv. At 4 weeks after -challenge, guinea
pigs were killed and organs were removed.
Protection was primarily assessed by measuring bacterial
load in lungs and spleen and comparing the vaccinated
groups of animalswith the control group (saline). Guinea pigs
vaccinated with either BCG or MbΔp27-p55 were protected
compared to saline control (𝑃 < 0.001), in both lungs and
spleen. However, in the lungs, the protection conferred by the
mutant was statistically lower than that of BCG (Figure 2(b)).
A histopathological analysis of lungs and spleen lesions
revealed that both vaccinated groups (MbΔp27-p55 and
BCG) showed significantly reduced consolidation, foci of
necrosis/caseation, and foci of calcification when compared
with the unvaccinated group (Figure 2(c)). Again, guinea
pigs vaccinated with BCG showed significantly reduced lung
pathology when compared to animals vaccinated with the
mutant strain.
2.3. Assessment of the Immune Responses Induced in Cattle
after Inoculation of a M. bovis Strain Deleted in p27 and p55
Genes. In order to better understand the failure of MbΔp27-
p55 to protect bothmice and guinea pigs against tuberculosis,
we used the cattle model to evaluate the immune response
induced after infection with this mutant strain.
In peripheral blood monocyte cells (PBMCs) isolated 90
days after infection with the wild type strain, activation of
CD4+ cells increased upon stimulation with PPDB (𝑃 <
0.01) (Figure 3(a)). In contrast, PBMCs isolated from animals
infected withMbΔp27-p55 did not respond to specific stimu-
lationwith activation of CD4+ cells in any time point assayed.
We assessed the cytokine expression profile in PBMCs
by measuring cytokine mRNAs after stimulating the cells
with PPDB (Figure 3(b)). Values for sequential samples were
normalized to values before inoculation for each animal.
Given that there are available ELISA commercial assays to
detect bovine IFN𝛾 we used this methodology instead of
quantification of IFN𝛾mRNA by RT-qPCR.
At 90 days after-infection (dpi), the expression of
interleukin-2 (IL-2) in PBMCs was upregulated only in the
group infected with the wild type strain, which is consistent
with the CD4+ proliferative response, detected only in this
animal group. Unexpectedly, only the group inoculated with
the mutant responded to PPDB stimulation with production
of IL-12 (𝑃 < 0.05), while the expression of TNF𝛼 was
upregulated in both animal groups with no significant differ-
ences between them (Figure 3(b)).
The expression of IL-4, a Th2 cytokine, was downregu-
lated in both groups (Figure 3(b)). This result is consistent
with the low level of IFN𝛾 detected at 90 dpi in both animal
groups. It has been proposed that IL-4 is produced to
compensate the inflammatory response induced by IFN𝛾.
At 120 dpi, the production of IFN𝛾 in culture supernatant
of PBMC stimulated with PPDB was significantly lower in
the group inoculated with the MbΔp27-p55 mutant than in
the group inoculated with the wild type strain. In fact, the
group inoculated with the mutant strain produced very low
quantities of IFN𝛾 after PPDB stimulation throughout this
study (Figure 3(c)).
Altogether, these results indicate that, although there is
upregulation of IL-12 and TNF𝛼, observed at 90 dpi, the lack
of P27 and P25 inM. bovis reduces the capacity of the bacilli
to induce a significantTh1 responsewhen inoculated in cattle.
3. Conclusions
In this study we demonstrated that aM. bovismutant in p27-
p55 operon did not confer better protection than BCG in both
mice and guinea pigs. MbΔp27-p55 was more virulent than
BCG in athymic mice, suggesting that its reduced protective
capacity was not due to an inability to establish an infection.
We found that the mutant induced in cattle the transcription
of IL-12 and TNF𝛼, two important Th1 cytokines. However,
in contraposition, CD4+ cells from cattle inoculated with the
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Figure 2: Protection assays in animal models. Organ bacillary loads after intratracheal challenge with M. bovis (a): BALB/c mice were
vaccinated with the MbΔp27-p55 or BCG and compared with control nonvaccinated animals. CFUs were determined after 30 days of
challenge. Organ bacillary loads (b) and histopathology (c) after aerosol challenge with M. tuberculosis: guinea pigs were vaccinated with
the MbΔp27-p55 or BCG and compared with control nonvaccinated animals. Histopathology and CFUs were determined after 30 days of
challenge. Data in (a) and (b) were analyzed using a two-tailed unpaired t-test, and data in (c) were analyzed using Mann-Whitney test
(∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001).
mutant did not proliferate in response to specific stimuli, and
the production of IFN𝛾 in blood was nearly undetectable in
this animal group. Therefore, altogether these results suggest
that the lack of p27-p55 operon reduces the capacity of M.
bovis to induce an adequate Th1 response, underlining the
immunogenic properties of P27. In the light of the results of
this study, aM. bovisdeleted in p55 virulence gene carrying an
intact p27 gene would be an attractive candidate to be tested
as TB vaccine.
4. Materials and Methods
4.1.Mouse Vaccination and Infections. Groups of female nude
(N:NIH (S)-𝐹𝑜𝑥𝑛𝐼nu) mice of 6–8 weeks old were used to
assess the virulence of MbΔp27-p55 strain.
BALB/c mice aging 6–8 weeks old were used for vac-
cination and challenge experiments. M. bovis NCTC 10772
strain (the parental strain of mutant MbΔp27-p55) was used
as challenge strain. This experiment was repeated twice.
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Figure 3: Continued.
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Figure 3: Response ofM. bovis-infected cattle to PPDB. (a) Percentages of the activated lymphocyte cell subsets CD4+ of PBMCs stimulated
with PPDB from animals inoculated with MbΔp27-p55 (𝑁 = 4, white square) or NCTC 10772 (𝑁 = 4-5, black triangle) at 0, 15, and 90
days after infection. Data were analyzed using the Wilcoxon matched pair test for cells with and without PPDB stimulation (∗statistically
significant 𝑃 < 0.05). The means ± SEM are indicated. (b) Relative cytokine gene expression. Gene expression was measured in PBMCs from
animals infected with eitherMbΔp27-p55 (𝑁 = 4, gray bars) or NCTC 10772 (𝑁 = 4, dark gray bars) stimulated with PPDB at 90 dpi. Relative
gene expression was calculated using the 2-ΔΔCt method with E correction, using pol II and gadphmRNA expression as reference genes and
the preimmune condition as the calibrator. Data were analyzed using a two-tailed unpaired Student’s t-test (∗𝑃 < 0.05). The bars indicate
the average ratios of infected animals/uninfected animals ± SEM. (c) IFN-𝛾 release in response to M. bovis antigens PPDB in blood from
animals inoculated withMbΔp27-p55 (gray squares), WT (black circles) at different time points (0, 30, 90, and 120 dpi). Results are expressed
as ΔO.D. (OD450 PPDB − OD450 PBS). Significance was determined by Mann-Whitney test (∗∗statistically significant 𝑃 < 0.01).
Experiments with mice were performed in compliance with
the regulations of Institutional Animal Care and Use Com-
mittee (CICUAE) of INTA. MbΔp27-p55 or BCG Pasteur
were delivered subcutaneously in a single dose at a concentra-
tion of 1×105 CFU. 60 days after vaccination the animals were
infected with 1, 25 × 105 CFU of M. bovis by intratracheally
instilation.
4.2. Guinea Pig Vaccination and Infection. Groups of 8
Dunkin-Hartley guinea pigs, weighing between 250 and 300 g
(free of infection), obtained from a commercial supplier
(Harlan, UK), were used to evaluate the efficacy of MbΔp27-
p55 compared with BCG Danish 1331 (Statens Serum Insti-
tute, Copenhagen, Denmark), both delivered subcutaneously
in a single dose at a concentration of 5 × 104 CFU, and a neg-
ative control unvaccinated group. Guinea pig experimental
workwas conducted according toUKHomeOffice legislation
for animal experimentation and was approved by the local
ethics committee.
Animals were infected with a low aerosol dose (10–
50CFU retained dose in the lung) of M. tuberculosis H37Rv
[4] 12 weeks after vaccination. Nose only aerosol chal-
lenge was performed using a fully contained Henderson
apparatus as previously described [5, 6] in conjunction
with the AeroMP (Biaera) control unit [7]. The aerosol
was generated from a water suspension containing 5 ×
10
6 CFU/ml in order to obtain an estimated retained, inhaled
dose of approximately 10–50CFU/lung [7]. At 4 weeks after-
challenge, guinea pigs were killed humanely by intraperi-
toneal injection of pentobarbital (Euthatal). Postmortem,
lungs and spleens were taken and processed for bacteriology
and histopathology analysis (subjective score), as described
previously [8]. A significant reduction inCFU (bacterial load)
and the nature and severity of the lesions (histopathology
score) of vaccinated animals when comparedwith the control
groups was considered a protective effect of the vaccine [9].
4.3. Cattle Infections and Immune Response Evaluations.
Cattle infections were performed in compliance with the
regulations of CICUAE and authorized by the National
Service of Agricultural and Food Health and Quality
(SENASA) and National Consultant Commission of Agricul-
tural Biotechnology (CONABIA). Group of Holstein-Fresian
calves (six months old) were inoculated intratracheally as
described previously [10] with 104–105 CFUs of either M.
bovis NCTC 10772 (𝑁 = 4-5) or MbΔp27-p55 (𝑁 =
4) and blood samples were taken at different points. After
three months of infection, the calves were euthanized and
then thin slices of lungs and lymph nodes of the head and
pulmonary region were analyzed for granuloma formations.
Only one of the animals inoculated with the wild type NCTC
10772 strain developed macroscopic lesions compatible with
tuberculosis (data not shown). These lesions were located
in retropharyngeal lymph nodes. No lesions were observed
in animals inoculated with the mutant MbΔp27-p55. Flow
cytometry determinations and cytokine expression analysis
were performed as previously described [10]. IGRA Inter-
feron Gamma (IFN-𝛾) release assays were performed on
blood samples by using ELISA-based kit (Bovigam; Prionics)
as previously described [10]. Duplicate samples for individual
antigens were analyzed.
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